Clarity Medical Group Holding Limited submitted its Monthly Return for the period ended 30 June 2026, confirming that no changes occurred to its share capital structure during the month. Key metrics remain unchanged versus May, underscoring capital stability and ongoing compliance with Hong Kong’s public-float rules.
Authorised Capital • The company’s authorised share capital stands at 5.00 billion ordinary shares with a par value of HKD0.01 each, equating to HKD50.00 million. No increases or reductions were recorded in June.
Issued Shares and Public Float • Issued shares (excluding treasury shares) were unchanged at 536.33 million. • Clarity Medical held zero treasury shares, keeping total issued shares also at 536.33 million. • The exchange-mandated public-float threshold of 25% was met as at 30 June 2026.
Equity Incentive Arrangements • No share options, warrants or convertibles were exercised or issued during the month. • Under the Share Award Plan approved on 23 November 2022, up to 43.97 million shares remain available for future grants; no new awards were issued in June. • The company’s previous share option scheme was terminated on 27 June 2023.
Regulatory Confirmation • The board affirmed full compliance with Hong Kong Listing Rules and other applicable regulations for all share-related matters during the reporting period.
With an unchanged share count and sufficient public float, Clarity Medical enters the second half of 2026 with a stable capital base and unutilised headroom for future share awards.
Comments